ctrl K

Sinopharm Group Co. Ltd. (SHTDF)

PNK: SHTDF · Real-Time Price · USD

2.35

0.00 (0.00%)

At close: Apr 28, 2025, 12:26 PM

Sinopharm Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	596.57B	552.15B	521.05B	456.41B	425.27B	344.53B	277.03B	258.12B
Cost of Revenue	548.06B	504.71B	477B	416.09B	387.74B	313.3B	254.64B	237.72B
Gross Profit	48.51B	47.43B	44.05B	40.32B	37.53B	31.23B	22.39B	20.4B
Operating Income	22.32B	20.6B	19.71B	17.76B	16.14B	15.4B	11.91B	10.21B
Interest Income	743.37M	542.77M	558.56M	676.36M	519.44M	513.42M	1.01B	561.47M
Pretax Income	19.51B	18.56B	17B	15.6B	13.76B	12.21B	10.17B	8.92B
Net Income	9.05B	8.53B	7.76B	7.19B	6.25B	5.83B	5.57B	4.64B
Selling & General & Admin	26.15B	24.9B	23.2B	21.19B	19.47B	15.89B	11.57B	10.73B
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	2.15B	29.05M	56.41M	12.47M	467K	3.59M	-24.53M	4.92M
Operating Expenses	28.3B	24.23B	22.61B	20.54B	19.03B	15.47B	11.17B	10.46B
Interest Expense	2.96B	3.52B	3.76B	3.42B	3.44B	4.16B	2.61B	2.04B
Selling & Marketing Expenses	17.47B	16.72B	15.44B	14.14B	12.56B	10.37B	7.38B	6.62B
Cost & Expenses	576.36B	528.94B	499.61B	436.63B	406.77B	328.77B	265.81B	248.17B
Income Tax Expense	4.5B	4.22B	3.94B	3.5B	3.14B	2.8B	2.3B	2.03B
Shares Outstanding (Basic)	3.12B	3.12B	3.11B	3.11B	2.97B	2.97B	2.97B	2.76B
Shares Outstanding (Diluted)	3.12B	3.12B	3.11B	3.11B	2.97B	2.97B	2.97B	2.77B
EPS (Basic)	2.90	2.73	2.49	2.31	2.11	1.97	1.88	1.68
EPS (Diluted)	2.90	2.73	2.49	2.31	2.10	1.96	1.88	1.68
EBITDA	26.9B	26.25B	24.68B	22.62B	20.32B	16.67B	13.43B	12.04B
EBIT	22.47B	22.08B	20.76B	19.02B	17.2B	15.28B	14.02B	10.97B
Depreciation & Amortization	4.43B	4.17B	3.92B	3.6B	3.11B	1.39B	1.24B	1.07B